Y-Intercept (HK)’s Astria Therapeutics ATXS Stock Holding History

Y-Intercept (HK)’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-81,501	Closed	-$1.07M	–	1545
2025 Q4	$1.07M	Buy	+81,501	New	+$973K	0.02%	952
2024 Q4	–	Sell	-10,509	Closed	-$116K	–	1173
2024 Q3	$116K	Sell	10,509 -175	-2%	-$1.95K	0.01%	1206
2024 Q2	$97.2K	Buy	+10,684	New	+$104K	0.01%	1260

Y-Intercept (HK)'s ATXS Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 81,501 shares — an estimated $1.07M sold.

Y-Intercept (HK) first reported a position in ATXS in Q2 2024 and held it in 3 quarters. The position peaked at $1.07M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Y-Intercept (HK) reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Y-Intercept (HK) sold 81,501 Astria Therapeutics shares in Q1 2026, an estimated $1.07M.
Y-Intercept (HK) first reported a position in Astria Therapeutics in Q2 2024 and held it in 3 quarters.
Y-Intercept (HK)'s Astria Therapeutics position peaked at $1.07M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.